Company intelligence / Profile preview

Guangdong Hinabiotech

Guangzhou, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Hina Biotech is a clinical-stage biotechnology company based in Guangdong, China, specializing in the development of mRNA-based therapeutics and vaccines. The company has established a comprehensive mRNA technology platform that encompasses sequence design, synthesis, and advanced lipid nanoparticle (LNP) delivery systems. Their primary focus includes the development of vaccines for infectious diseases, such as COVID-19, as well as exploring mRNA applications in oncology and protein replacement therapies. Hina Biotech also operates as a CDMO, providing end-to-end mRNA production services from R&D to pilot-scale manufacturing.

Therapeutic areas: OncologyInfectious Diseases
Modalities: mRNA-based drugsLipid nanoparticle delivery therapyVaccine
Industry: Biotech

Beyond the preview

Go deeper on Guangdong Hinabiotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangdong Hinabiotech.

Explore the full profile